Vitamin D Status and Supplementation in Patients Undergoing Spine Surgery: A Systematic Review and Meta-analysis

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background

Vitamin D may influence bone healing and recovery after spine surgery, but its clinical effects remain uncertain.

Objective

To evaluate clinical, functional, and bone-related outcomes associated with vitamin D status and supplementation in patients undergoing spine surgery.

Methods

This systematic review and meta-analysis was registered in PROSPERO (CRD420261321165) and reported according to PRISMA 2020. PubMed/MEDLINE, Scopus, Web of Science, Embase, and the Cochrane Library were searched from inception through 15 January 2026. Random-effects meta-analyses used mean differences (MDs) for continuous outcomes and risk ratios (RRs) for dichotomous outcomes. Direct supplementation analyses were prioritized; analyses combining supplementation, baseline vitamin D status, or co-interventions were exploratory. Risk of bias was assessed using design-specific Joanna Briggs Institute tools.

Results

Thirteen studies were included. Four supplementation studies involving 177 participants showed no significant reduction in postoperative pain (MD −0.82, 95% CI −2.50 to 0.86; I² = 84.3%). Three studies involving 277 participants showed lower Oswestry Disability Index scores in an exploratory analysis (MD −6.40, 95% CI −10.41 to −2.39; I² = 96.8%). Three supplementation studies involving 128 participants showed no significant improvement in fusion rate (RR 1.17, 95% CI 0.78–1.74; I² = 31.5%). An exploratory four-study fusion analysis was also nonsignificant (RR 1.24, 95% CI 0.98–1.57; I² = 45.5%).

Conclusion

Current evidence does not establish that vitamin D supplementation independently improves postoperative pain or fusion rates after spine surgery. Possible benefits for disability and other bone-related outcomes remain uncertain because of small study numbers, heterogeneity, co- interventions, and residual confounding. Larger randomized trials stratified by baseline vitamin D status are needed.

Article activity feed